| |
 |
|
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/246.1 |
Bacillus |
69 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
69 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
31 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
78 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
98 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
47 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
150 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
196 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
30 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
55 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
233 |
| 424/264.1 |
Mycoplasma |
46 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
93 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
88 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
81 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
90 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
142 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
107 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
300 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
329 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
94 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
42 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
82 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6350457 |
Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
Feb. 26, 2002 |
| 6348198 |
Lactoferrin receptor protein |
Feb. 19, 2002 |
| 6348340 |
Compounds |
Feb. 19, 2002 |
| 6348342 |
Compounds |
Feb. 19, 2002 |
| 6348578 |
Apt |
Feb. 19, 2002 |
| 6348579 |
FtsL |
Feb. 19, 2002 |
| 6346608 |
MecB |
Feb. 12, 2002 |
| 6344201 |
Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cadA, to reduce pathogenicity in a bacteria or to combat pathogeni |
Feb. 5, 2002 |
| 6344540 |
PAI |
Feb. 5, 2002 |
| 6342230 |
Materials and methods for prevention or reduction of the severity of heartwater |
Jan. 29, 2002 |
| 6342231 |
Haemophilus parasuis vaccine and diagnostic |
Jan. 29, 2002 |
| 6340455 |
Testkit and method |
Jan. 22, 2002 |
| 6340463 |
Identification of antigenic peptide sequences |
Jan. 22, 2002 |
| 6335424 |
ribG |
Jan. 1, 2002 |
| 6331303 |
LKTA deletion mutant of P. haemolytica |
Dec. 18, 2001 |
| 6328972 |
Compositions and methods for inducing cytotoxic T lymphocyte responses by immunization with protein antigens |
Dec. 11, 2001 |
| 6328978 |
Methods for the treatment of immunologically-mediated skin disorders |
Dec. 11, 2001 |
| 6328989 |
Use of bicozamycin for the manufacture of a medicament for treating infections with enterohemorrhagic e. coli |
Dec. 11, 2001 |
| 6326462 |
RibH |
Dec. 4, 2001 |
| 6322809 |
Liposomes containing particulate materials |
Nov. 27, 2001 |
| 6316005 |
Borrelia burgdorferi bacterin |
Nov. 13, 2001 |
| 6312700 |
Method for enhancing an antigen specific immune response with OX-40L |
Nov. 6, 2001 |
| 6309648 |
Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
Oct. 30, 2001 |
| 6306402 |
Compounds and methods for the diagnosis and treatment of EHRLICHIA infection |
Oct. 23, 2001 |
| 6306404 |
Adjuvant and vaccine compositions containing monophosphoryl lipid A |
Oct. 23, 2001 |
| 6307022 |
Def |
Oct. 23, 2001 |
| 6303124 |
Compounds |
Oct. 16, 2001 |
| 6303129 |
Production of borrelia burgdorferi vaccine, product produced thereby and method of use |
Oct. 16, 2001 |
| 6299880 |
Cell surface protein compounds |
Oct. 9, 2001 |
| 6299883 |
Tarf |
Oct. 9, 2001 |
| 6300101 |
Methods and compositions including a 13kD B. burgdorferi protein |
Oct. 9, 2001 |
| 6296849 |
Methods and compositions including a 13kDa B. burgdorferi protein |
Oct. 2, 2001 |
| 6296851 |
Integral membrane proteins of Staphylococcus aureus |
Oct. 2, 2001 |
| 6296855 |
17-KDA Brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits |
Oct. 2, 2001 |
| 6294175 |
Compounds |
Sep. 25, 2001 |
| 6290962 |
Urease-based vaccine and treatment for helicobacter infection |
Sep. 18, 2001 |
| 6290970 |
Transferrin receptor protein of Moraxella |
Sep. 18, 2001 |
| 6287555 |
Method and vaccine for prevention of over-production of acid in the rumen or gut of animals |
Sep. 11, 2001 |
| 6287573 |
Method and vaccine for treatment of Pythiosis insidiosi in humans and lower animals |
Sep. 11, 2001 |
| 6287575 |
Vaccine against papillomatous digital dermatitis (PDD) |
Sep. 11, 2001 |
| 6284238 |
Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods |
Sep. 4, 2001 |
| 6280735 |
ribG |
Aug. 28, 2001 |
| 6280741 |
Equine treatment and method of administering such treatment |
Aug. 28, 2001 |
| 6277379 |
Use of purified invaplex from gram negative bacteria as a vaccine |
Aug. 21, 2001 |
| 6277381 |
Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
Aug. 21, 2001 |
| 6274144 |
Method for generating antibodies to saccharide fragments |
Aug. 14, 2001 |
| 6270775 |
Streptococcal C5a peptidase vaccine |
Aug. 7, 2001 |
| 6270777 |
Conserved metalloprotease epitopes |
Aug. 7, 2001 |
| 6270982 |
Methods and compositions for the detection of bacterial endotoxins |
Aug. 7, 2001 |
| 6267961 |
Direct methods for molar-mass determination of fragments of Haemophilus influenzae type b capsular polysaccharides and vaccine preparation |
Jul. 31, 2001 |
|
|
|
